Biochips Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032 - PowerPoint PPT Presentation

About This Presentation
Title:

Biochips Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032

Description:

According to the latest research report by IMARC Group, The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 10 May 2024
Slides: 17
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Biochips Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032


1
Global Biochips Market Research and Forecast
Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Biochips Market Global Industry Trends,
    Share, Size, Growth, Opportunity and Forecast
    2024-2032," the global biochips market size
    reached US 19.6 Billion in 2023.
  • Biochips are miniaturized medical devices that
    are used in molecular laboratories to carry out
    several biochemical reactions simultaneously.
    They can rapidly screen a number of biological
    analytes for an array of applications, such as
    disease diagnosis and detection of hazardous
    biological agents in a system.
  • They offer several advantages, including the
    ability to perform high-throughput analysis,
    allowing researchers to analyze thousands of
    samples in a short amount of time, and are also
    highly sensitive and specific, enabling the
    detection of low concentrations of biomolecules
    with high accuracy. They are utilized to
    determine gene expression, detect mutations,
    identify proteins, and screen for drug
    candidates. Consequently, they are used in a
    variety of applications, such as genomics,
    proteomics, and drug discovery. They can also be
    adopted in medical diagnostics, including
    detecting infectious diseases or cancer
    biomarkers.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/biochips-market/request
    sample

4
Report Description
  • Global Biochips Market Trends
  • The increasing prevalence of chronic disorders
    among the masses is driving the global market.
    Coupled with this, the growing consumer health
    concerns about several viral infections and
    immunological disorders are propelling the demand
    for biochips in new drug discovery and
    development activities. Moreover, the development
    of advanced biochip technologies, such as
    microfluidics and nanotechnology, has led to the
    creation of more sophisticated and efficient
    biochips that can perform a wide range of
    diagnostic and research applications, which is
    augmenting the market. Additionally, the
    increasing demand for non-invasive diagnostic
    tools is supporting the demand for biochips since
    they offer a non-invasive way to diagnose
    diseases, thereby reducing the risks and costs
    associated with invasive diagnostic procedures.
    Besides, the governments of several countries are
    heavily investing in biochip research and
    development to advance healthcare and life
    sciences research, which is creating a positive
    market outlook. The market is further driven by
    the widespread utilization of biochips in
    agriculture to analyze plant and soil samples,
    allowing for more precise and efficient farming
    practices. In line with this, the extensive
    adoption of biochips to monitor environmental
    conditions and detect pollutants in air, water,
    and soil is further strengthening the demand
    worldwide. Furthermore, the growing investments
    in the healthcare sector pertaining to cancer
    genomics, human proteome, and DNA analysis are
    impacting the market favorably.
  • Looking forward, the market is anticipated to
    reach a value of US 64.3 Billion by 2032,
    exhibiting a growth rate (CAGR) of 13.7 during
    2024-2032.
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/biochips-market

5
Report Segmentation
  • Breakup by Product Type
  • DNA Chip
  • Protein Chip
  • Lab-On-a-Chip
  • Enzyme Chip
  •  
  • Breakup by Fabrication Technique
  • Microarray
  • Microfluidic
  • Breakup by Analysis Method
  • Electrophoresis
  • Luminescence
  • Mass Spectrometry
  • Electrical Signals
  • Magnetism

6
Report Segmentation
  • Breakup by Application
  • Molecular Analysis
  • Hybridization
  • Protein
  • Immunological
  • Biomolecules
  • Biomarker
  • Others
  • Diagnosis
  • Gene Diagnosis
  • Oncology
  • Inflammatory
  • Others
  • Non-Biological Usage
  • Breakup by End User
  • Pharmaceutical and Biotechnology Companies

7
Report Segmentation
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Others
  • Breakup by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

8
Competitive Landscape with Key Players
  • Agilent Technologies, Inc.
  • bioMérieux SA
  • Bio-RAD Laboratories, Inc.
  • CapitalBio Corporation
  • Dynamic Biosensors GmbH
  • EMD Millipore Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Thermo Fisher Scientific Inc.

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
11
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Biochips Market   
    5.1    Market Overview    5.2    Market
    Performance    5.3    Impact of COVID-19  5.4
       Market Forecast
  • 6     Market Breakup by Product Type
  • 6.1 DNA Chip
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
  • 6.2 Protein Chip
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast       

12
Table of Contents
  • 6.4 Enzyme Chip
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
  • 7 Market Breakup by Fabrication Technique
  • 7.1 Microarray
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
  • 7.2 Microfluidic
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
  • 8 Market Breakup by Analysis Method
  • 8.1 Electrophoresis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
  • 8.2 Luminescence
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
  • 8.3.1 Market Trends

13
Partial List of Clients
14
Partial List of Clients
15
Disclaimer
  • 2024 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

16
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us
Write a Comment
User Comments (0)
About PowerShow.com